ArticleLeukemia2024

Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemia.

Richard L Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.